We determined that HE4 has the ability to mediate gene expression in peripheral blood mononuclear cells (PBMCs), and then evaluated HE4's effect on one of its identified targets, DUSP6, ultimately investigating how this relationship affects immune cytotoxicity against ovarian cancer cells. The gene discussed is WFDC2; the disease is ovarian carcinoma.